What is “Ohtuvayre” and why are people looking it up on DrugPatentWatch?
“Ohtuvayre” is the brand name for ensifentrine, a respiratory drug used for COPD. People searching “Ohtuvayre DrugPatentWatch” are usually trying to find the patent and exclusivity status—such as what patents cover it, whether any are expiring soon, and how that could affect the timing of generic or biosimilar-style competition in the US. DrugPatentWatch is one of the places patients, researchers, and attorneys check for that patent timeline information.
You can search the latest entries here: DrugPatentWatch: Ohtuvayre (ensifentrine)
What kinds of patent/exclusivity details does DrugPatentWatch typically show?
When you open an entry on DrugPatentWatch for a specific product, the information is generally organized around the legal “barriers” to generic competition. That usually includes patent numbers tied to the product and dates (or estimated timing) for when protection may lapse, which helps explain why a drug may stay brand-only for longer than expected.
When could Ohtuvayre’s protections expire (and why do dates matter)?
For drugs like ensifentrine, timing matters because companies often use the patent landscape to judge:
- whether a generic path could open soon after patent expiration
- how long market exclusivity might extend beyond the last patent date
- what “challenge” filings might be possible (in the US context)
DrugPatentWatch is commonly used to get a quick view of those deadlines and the specific patents listed for a brand.
Who else is affected if Ohtuvayre patents expire?
Patent expiry can shift the competitive field by potentially enabling competitors to seek approval for versions of the therapy, depending on the legal protections still in force. That impacts:
- potential generic/alternative manufacturers
- payers and formularies as lower-cost options become available
- patients waiting for broader access at lower prices
If you meant something specific (patents, exclusivity, or a full summary), which one?
DrugPatentWatch pages can be long and cover multiple patents and related filings. If you tell me what you want (for example: “When is the first Ohtuvayre patent expiring?” or “What patents are listed on DrugPatentWatch?”), I can help interpret the key dates and what they likely mean for competition.
Sources
- DrugPatentWatch (Ohtuvayre / ensifentrine search)